Weighing Risks and Benefits: Patient Perceptions on Using Medications for Opioid Use Disorder During and After Pregnancy
Despite perceived risks, pregnant and postpartum persons with OUD have many motivations to use MOUD during pregnancy that may shift in the postpartum period. Our findings underscore the importance of education and shared decision-making and emphasize the need for leveraging pre- and postnatal motivation for MOUD during these conversations and throughout course of treatment.
Authors
- Aimee L. McRae‐Clark (ORCID: https://orcid.org/0000-0002-9774-318X)
- Marie J. Hayes (ORCID: https://orcid.org/0000-0002-7240-4966)
- Sara M. Witcraft (ORCID: https://orcid.org/0000-0001-8890-0465)
- Christin A. Mujica (ORCID: https://orcid.org/0000-0001-5033-0639)
- Anna E. Eitel (ORCID: https://orcid.org/0009-0006-5862-6841)
- Constance Guille (ORCID: https://orcid.org/0000-0001-6004-3027)
Institutions
- Medical University of South Carolina (US)
- University of Arkansas at Fayetteville (US)
Publication Details
- Journal
- Substance Use & Addiction Journal
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1177/29767342251326344
- Primary Topic
- Prenatal Substance Exposure Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute on Drug Abuse
- Office of Research on Women's Health